Abstract
AbstractRapid advancements in high-throughput omics technologies and experimental protocols have led to the generation of vast amounts of biomolecular data on cancer that now populates several online databases and resources. Cancer systems biology models built on top of this data have the potential to provide specific insights into complex multifactorial aberrations underpinning tumor initiation, development, and metastasis. Furthermore, the annotation of these single- or multi-scale models with patient data can additionally assist in designing personalized therapeutic interventions as well as aid in clinical decision-making. Here, we have systematically reviewed the emergence and evolution of (i) repositories with scale-specific and multiscale biomolecular cancer data, (ii) systems biology models developed using this data, (iii) associated simulation software for development of personalized cancer therapeutics, and (iv) translational attempts to pipeline multi-scale panomics data for data-driven in silico clinical oncology. The review concludes by highlighting that the absence of a generic, zero-code, panomics-based multi-scale modeling pipeline and associated software framework, impedes the development and seamless deployment of personalized in silico multi-scale models in clinical settings.
Publisher
Cold Spring Harbor Laboratory
Reference365 articles.
1. National Cancer Act of 1971 - National Cancer Institute.
2. The war on cancer: have we won the battle but lost the war?;Oncotarget,2010
3. The 'War on Cancer' and its impact
4. National Cancer Act of 1971 [Internet]. Available from: https://www.cancer.gov/about-nci/overview/history/national-cancer-act-1971
5. Precision Medicine for Personalized Cancer Therapy;International journal of biological sciences,2015
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献